Left Menu
Development News Edition

No restriction on Patanjali's Coronil kit, will be available across country: Ramdev

Yog guru Ramdev on Wednesday claimed that there is no restriction on Patanjali Ayurved's Swasari Coronil kit for "COVID management" and now it will be available across the country.

ANI | Haridwar (Uttarakhand) | Updated: 01-07-2020 13:38 IST | Created: 01-07-2020 13:38 IST
No restriction on Patanjali's Coronil kit, will be available across country: Ramdev
Ramdev addressing a press conference in Haridwar on Wednesday. [Photo/ANI]. Image Credit: ANI

Yog guru Ramdev on Wednesday claimed that there is no restriction on Patanjali Ayurved's Swasari Coronil kit for "COVID management" and now it will be available across the country. Addressing a press conference here, he said: "AYUSH Ministry said that Patanjali has done appropriate work for COVID management. It said that Patanjali has started working in the right direction. We have procured a license for these medicines from the state department which is connected with AYUSH Ministry... The AYUSH Ministry said that Patanjali worked for COVID management. The treatment word is not used. These medicines have no metallic items."

"We have no disagreement with AYUSH Ministry. Now, there is no restriction on Coronil, Swashhari, Giloy, Tulsi, Ashwagandha. From today, these medicines (Swasari Coronil Kit) will be available in the country without any legal restrictions. There is no restriction on it. I thank the AYUSH Ministry and the Narendra Modi government," he said. Last week, Patanjali Ayurved launched 'Coronil and Swasari' claiming it to be Ayurvedic cure for treating COVID-19 and said clinical trials have shown favourable results.

Later, the AYUSH Ministry said that it has taken cognizance of news in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved Ltd, Haridwar and said the company has been asked to "stop advertising/publicising such claims till the issue is duly examined". Ramdev said that Patanjali has conducted randomized, double-blinded, and placebo-controlled clinical trials. "In 3 days, 69 per cent, 100 per cent patients tested negative in 7 days. We submitted data to the Ayush Ministry. We have submitted research of our clinical trials to Ayush Ministry. Our research is in line with all protocols," he said

He informed that Patanjali has completed three-level research of more than 10 diseases. "We have done clinical trials on coronavirus. We have completed three-level research of more than 10 diseases including hypertension, heart diseases, asthma, arthritis, dengue, chikungunya, swine flu. We are not doing research on virology for the first time," he said.

An FIR was registered in Jaipur against Ramdev, Patanjali CEO Acharya Balkrishna and others for their claim to develop a cure for the coronavirus. Speaking on this, Ramdev said: "It seems that work of Yog and Ayurved inside India is a crime. FIRs have been lodged at hundreds of places in the same way cases are registered a traitor and a terrorist."

"We have a team of 500 scientists who are working day and night. We have showcased data of our clinical trials on coronavirus, it has hit hard drug mafia, MNCs, forces which were working against swadeshi," he said. (ANI)



COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

COVID-19: Weighing up the benefits and limitations of edtech platforms

Edtech companies shouldnt focus on merely pushing contents, but to provide an interactive, effective teaching and learning environment. ...


Latest News

Yankees' LeMahieu, Cessa test positive for COVID-19

New York Yankees infielder DJ LeMahieu and right-hander Luis Cessa have tested positive for COVID-19 and are away from the team, the club announced Saturday. We are hopeful their absence will be a short time but they are not here at this po...

China reports eight new coronavirus cases in mainland

China reported eight new coronavirus cases in the mainland for July 4, compared with three cases a day earlier, the health authority said on Sunday. Six of the new infections were imported cases, according to a statement by the National Hea...

Incumbent Koike seen ahead as Tokyo votes for governor amid pandemic

Voters in Tokyo went to the polls on Sunday to elect their governor, with incumbent Yuriko Koike forecast to clinch a victory, as Japans capital struggles with rebounding coronavirus infections and prepares for next years Olympics.Cases of ...

Mexico's COVID deaths pass 30,000, world's 5th highest total

Mexico has topped 30,000 COVID-19 deaths, overtaking France as the country with the fifth-highest death toll since the coronavirus outbreak began. Officials reported 523 more confirmed coronavirus deaths for Saturday, bringing the nations t...

Give Feedback